Wikipedia -WSS

Wikipedia

author：explore 2025-08-12 06:42:11 - browse：288

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Beware the threat of staffing cuts at the CDC

WSS

Address the ethical violations that led to 'Three Identical Strangers'

Ionis has late

Health tech startups drop sharply from 2021 highs

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Eye stem cell transplant could help restore vision in injured people

After a drawn out lobbying fight, ARPA

hotspot

Wikipedia

focus

How to save PrEP access — and even expand it

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Tori Bowie and the unacceptable rates of Black maternal death

New details revealed about Purdue's marketing of OxyContin

Duchenne breakthrough therapy leaves behind pioneering families

The pain doctors face in trying to build their families

Drug repurposing or repositioning? The language matters

Eye stem cell transplant could help restore vision in injured people

BioMarin wins approval for gene therapy to treat hemophilia A

Paxlovid should be available without a positive Covid test

hotspot

Medicaid, Medicare dual

Health tech startups drop sharply from 2021 highs

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Clinical trials must include more disabled people

Trump's false claims about Georgia's 2020 election long debunked

Paxlovid should be available without a positive Covid test

explore

explore

hotspot

entertainment